Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Eur J Haematol

Retrieve available abstracts of 48 articles:
HTML format
Text format



Single Articles


    May 2017
  1. NAHI H, Genell A, Walinder G, Uttervall K, et al
    Incidence, characteristics and outcome of solitary plasmacytoma and plasma cell leukemia. Population based data from the Swedish Myeloma Register.
    Eur J Haematol. 2017 May 22. doi: 10.1111/ejh.12907.
    PubMed     Text format     Abstract available


    April 2017
  2. KOZLOWSKI P, Lennmyr E, Ahlberg L, Bernell P, et al
    Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden.
    Eur J Haematol. 2017 Apr 18. doi: 10.1111/ejh.12896.
    PubMed     Text format     Abstract available


  3. LARFORS G, Sandin F, Richter J, Sjalander A, et al
    The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia.
    Eur J Haematol. 2017;98:398-406.
    PubMed     Text format     Abstract available


  4. RAUTENBERG C, Nachtkamp K, Dienst A, Schmidt PV, et al
    Sorafenib and azacitidine as salvage therapy for relapse of FLT3-ITD mutated AML after allo-SCT.
    Eur J Haematol. 2017;98:348-354.
    PubMed     Text format     Abstract available


    March 2017
  5. ZADA M, Lerner D, Piltz Y, Perry C, et al
    Familial Chronic Lymphocytic Leukemia in Israel: A Disproportionate Distribution Among Ashkenazi Jews.
    Eur J Haematol. 2017 Mar 31. doi: 10.1111/ejh.12889.
    PubMed     Text format     Abstract available


  6. TAGHILOO S, Allahmoradi E, Tehrani M, Hossein-Nataj H, et al
    Frequency and functional characterization of Exhausted CD8+ T-cells in chronic lymphocytic leukemia.
    Eur J Haematol. 2017 Mar 17. doi: 10.1111/ejh.12880.
    PubMed     Text format     Abstract available


  7. NOLTE F, Mossner M, Jann JC, Nowak D, et al
    Concomitant MDS with isolated 5q deletion and MGUS: case report and review of molecular aspects.
    Eur J Haematol. 2017;98:302-310.
    PubMed     Text format     Abstract available


  8. AL-SAWAF O, Fischer K, Herling CD, Ritgen M, et al
    Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial.
    Eur J Haematol. 2017;98:254-262.
    PubMed     Text format     Abstract available


    February 2017
  9. LAZAREVIC V, Rosso A, Juliusson G, Antunovic P, et al
    Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: a population-based study from the Swedish AML Registry.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12861.
    PubMed     Text format     Abstract available


  10. SEKINE M, Kubuki Y, Kameda T, Takeuchi M, et al
    Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12863.
    PubMed     Text format     Abstract available


  11. THOTA S, Advani A
    Inotuzumab ozogamicin in relapsed b-cell acute lymphoblastic leukemia.
    Eur J Haematol. 2017 Feb 2. doi: 10.1111/ejh.12862.
    PubMed     Text format     Abstract available


  12. GONZALEZ-GASCON Y MARIN I, Martin AA, Hernandez-Sanchez M, Robledo C, et al
    Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL.
    Eur J Haematol. 2017;98:142-148.
    PubMed     Text format     Abstract available


    January 2017
  13. MORI N, Ohwashi-Miyazaki M, Yoshinaga K, Okada M, et al
    Tumor suppressor gene methylation on the short arm of chromosome 1 in chronic myelogenous leukemia.
    Eur J Haematol. 2017 Jan 27. doi: 10.1111/ejh.12857.
    PubMed     Text format     Abstract available


  14. CAHU X, Carre M, Recher C, Pigneux A, et al
    Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia.
    Eur J Haematol. 2017 Jan 25. doi: 10.1111/ejh.12850.
    PubMed     Text format     Abstract available


  15. SODERLUND S, Dahlen T, Sandin F, Olsson-Stromberg U, et al
    Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register.
    Eur J Haematol. 2017;98:57-66.
    PubMed     Text format     Abstract available


    December 2016
  16. FATHI AT, Chen YB
    The Role of FLT3 Inhibitors in the Treatment of FLT3 Mutated Acute Myeloid Leukemia.
    Eur J Haematol. 2016 Dec 21. doi: 10.1111/ejh.12841.
    PubMed     Text format     Abstract available


  17. ALGRIN C, Golmard JL, Michallet M, Reman O, et al
    Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia.
    Eur J Haematol. 2016 Dec 10. doi: 10.1111/ejh.12836.
    PubMed     Text format     Abstract available


    October 2016
  18. KRON F, Kutsch N, Kostenko A, Dohle I, et al
    Economic evaluation of Chronic Lymphatic Leukemia from a Hospital Management Perspective.
    Eur J Haematol. 2016 Oct 11. doi: 10.1111/ejh.12817.
    PubMed     Text format     Abstract available


  19. HEMMATI PG, Vuong LG, Terwey TH, Jehn CF, et al
    Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
    Eur J Haematol. 2016 Oct 5. doi: 10.1111/ejh.12815.
    PubMed     Text format     Abstract available


    September 2016
  20. HEIBLIG M, Elhamri M, Jeune CL, Laude MC, et al
    Acute myeloid leukemia in the elderly (age 70 years or older): Long-term survivors.
    Eur J Haematol. 2016 Sep 26. doi: 10.1111/ejh.12811.
    PubMed     Text format     Abstract available


  21. SILLA L, Dulley F, Saboya R, Kerbauy F, et al
    Brazilian guidelines on HSCT in acute myeloid leukemia.
    Eur J Haematol. 2016 Sep 13. doi: 10.1111/ejh.12808.
    PubMed     Text format     Abstract available


  22. DEGWERT N, Latuske E, Vohwinkel G, Stamm H, et al
    Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.
    Eur J Haematol. 2016;97:239-44.
    PubMed     Text format     Abstract available


    August 2016
  23. ROMBOUT A, Verhasselt B, Philippe J
    Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications.
    Eur J Haematol. 2016 Aug 9. doi: 10.1111/ejh.12789.
    PubMed     Text format     Abstract available


  24. HEHLMANN R
    CML - we are not there yet.
    Eur J Haematol. 2016;97:107.
    PubMed     Text format    


  25. KRISTENSEN L, Kristensen T, Abildgaard N, Royo C, et al
    LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.
    Eur J Haematol. 2016;97:175-82.
    PubMed     Text format     Abstract available


  26. THIELEN N, Visser O, Ossenkoppele G, Janssen J, et al
    Chronic myeloid leukemia in the Netherlands: a population-based study on incidence, treatment, and survival in 3585 patients from 1989 to 2012.
    Eur J Haematol. 2016;97:145-54.
    PubMed     Text format     Abstract available


    July 2016
  27. ANSARI J, Naqash AR, Munker R, El-Osta H, et al
    Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment.
    Eur J Haematol. 2016;97:9-16.
    PubMed     Text format     Abstract available


    May 2016
  28. MALMBERG EB, Stahlman S, Rehammar A, Samuelsson T, et al
    Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next generation sequencing.
    Eur J Haematol. 2016 May 20. doi: 10.1111/ejh.12780.
    PubMed     Text format     Abstract available


  29. GEISSLER K, Jager E, Barna A, Sliwa T, et al
    In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemia.
    Eur J Haematol. 2016 May 9. doi: 10.1111/ejh.12773.
    PubMed     Text format     Abstract available


  30. WOLF D, Mayer K
    When and how to 'FLAMSA-RIC' in acute myeloid leukemia?
    Eur J Haematol. 2016;96:445-6.
    PubMed     Text format    


  31. HOLTICK U, Shimabukuro-Vornhagen A, Chakupurakal G, Theurich S, et al
    FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.
    Eur J Haematol. 2016;96:475-82.
    PubMed     Text format     Abstract available


    April 2016
  32. SCHMOHL JU, Nuebling T, Wild J, Kroell T, et al
    RANK-L expression on blasts in patients with acute myeloid leukemia is associated with survival, PD-1/PD-1L expression has no impact.
    Eur J Haematol. 2016 Apr 20. doi: 10.1111/ejh.12762.
    PubMed     Text format     Abstract available


    March 2016
  33. SAINI L, Brandwein J, Turner R, Larratt L, et al
    The FLAG Chemotherapy Regimen Is an Alternative to Anthracycline Based Therapy for the Treatment of Acute Myeloid Leukemia for Patients with Pre-Existing Cardiac Disease.
    Eur J Haematol. 2016 Mar 29. doi: 10.1111/ejh.12757.
    PubMed     Text format     Abstract available


  34. SARANG Z, Gyurina K, Scholtz B, Kiss C, et al
    Altered expression of autophagy-related genes might contribute to glucocorticoid resistance in precursor B-cell type acute lymphoblastic leukemia.
    Eur J Haematol. 2016 Mar 7. doi: 10.1111/ejh.12753.
    PubMed     Text format     Abstract available


    February 2016
  35. BARON F, Nagler A
    Best allogeneic transplantation approach for AML patients in first CR: is delayed unrelated donor bone marrow transplantation better than immediate unrelated cord blood transplantation?
    Eur J Haematol. 2016 Feb 10. doi: 10.1111/ejh.12745.
    PubMed     Text format     Abstract available


  36. GUNNARSSON N, Sandin F, Hoglund M, Stenke L, et al
    Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.
    Eur J Haematol. 2016 Feb 2. doi: 10.1111/ejh.12743.
    PubMed     Text format     Abstract available


  37. DAHLEN T, Kalin M, Cederlund K, Nordlander A, et al
    Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
    Eur J Haematol. 2016;96:175-80.
    PubMed     Text format     Abstract available


    January 2016
  38. LIM SJ, Lim MJ, Raptis A, Hou JZ, et al
    Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant.
    Eur J Haematol. 2016;96:55-9.
    PubMed     Text format     Abstract available


  39. GENTILE M, Cutrona G, Molica S, Ilariucci F, et al
    Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
    Eur J Haematol. 2016;96:36-45.
    PubMed     Text format     Abstract available


    December 2015
  40. YANADA M, Kanda J, Ohtake S, Fukuda T, et al
    Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission.
    Eur J Haematol. 2015 Dec 18. doi: 10.1111/ejh.12723.
    PubMed     Text format     Abstract available


  41. BASSAN R, Maino E, Cortelazzo S
    Lymphoblastic lymphoma: an updated review on biology, diagnosis and treatment.
    Eur J Haematol. 2015 Dec 17. doi: 10.1111/ejh.12722.
    PubMed     Text format     Abstract available


  42. MAURER C, Pflug N, Bahlo J, Kluth S, et al
    Bendamustine and Rituximab in Combination with Lenalidomide in Patients with Chronic Lymphocytic Leukemia.
    Eur J Haematol. 2015 Dec 8. doi: 10.1111/ejh.12714.
    PubMed     Text format     Abstract available


  43. TAMARA S, Irina S, Alexey B, Nataliya P, et al
    The Ability of Multipotent Mesenchymal Stromal Cells from the Bone Marrow of Patients with Leukemia to Maintain Normal Hematopoietic Progenitor Cells.
    Eur J Haematol. 2015 Dec 8. doi: 10.1111/ejh.12713.
    PubMed     Text format     Abstract available


    July 2015
  44. OSTENDORF BN, Terwey TH, Hemmati PG, Bohmer D, et al
    Severe radiotoxicity in an allogeneic transplant recipient with a heterozygous ATM mutation.
    Eur J Haematol. 2015;95:90-2.
    PubMed     Text format     Abstract available


    June 2015
  45. PULTE D, Redaniel MT, Bird J, Jeffreys M, et al
    Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century.
    Eur J Haematol. 2015;94:540-5.
    PubMed     Text format     Abstract available


    May 2015
  46. LAZAREVIC V, Horstedt AS, Johansson B, Antunovic P, et al
    Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.
    Eur J Haematol. 2015;94:419-23.
    PubMed     Text format     Abstract available


  47. SCOPIM-RIBEIRO R, Machado-Neto JA, Campos Pde M, Silva CA, et al
    Ten-eleven-translocation 2 (TET2) is downregulated in myelodysplastic syndromes.
    Eur J Haematol. 2015;94:413-8.
    PubMed     Text format     Abstract available


    April 2015
  48. FALK IJ, Willander K, Chaireti R, Lund J, et al
    TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome.
    Eur J Haematol. 2015;94:355-62.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: